Centro Gaucho Integrado de Oncologia, Hematologia, Ensino e Pesquisa Ltda
Porto Alegre, Rio Grande do Sul 90470340
1 studies enrolling now · 2 studies all time
What they study most
Advanced Melanoma, Myelofibrosis
Studies at this site
- IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) — Recruiting now
- A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment — Running, not enrolling